• Home
  • Practice Focus
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
    • How I Do It
    • TRIO Best Practices
  • Business of Medicine
    • Health Policy
    • Legal Matters
    • Practice Management
    • Tech Talk
    • AI
  • Literature Reviews
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Career
    • Medical Education
    • Professional Development
    • Resident Focus
  • ENT Perspectives
    • ENT Expressions
    • Everyday Ethics
    • From TRIO
    • The Great Debate
    • Letter From the Editor
    • Rx: Wellness
    • The Voice
    • Viewpoint
  • TRIO Resources
    • Triological Society
    • The Laryngoscope
    • Laryngoscope Investigative Otolaryngology
    • TRIO Combined Sections Meetings
    • COSM
    • Related Otolaryngology Events
  • Search

Prescription Drug Benefit Primer

by Pamela Kumar, RN • April 1, 2006

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
Print-Friendly Version

The biggest number of glitches were reported to be with dually eligible individuals who were automatically enrolled by Medicaid into a private Part D plan. On January 15, the White House ordered insurers to supply all beneficiaries in need with a 30-day supply of medication, no matter what.3 Federal officials said that this measure may be extended if necessary. Bill Vaughan, a health lobbyist and senior policy analyst at Washington, D.C.-based Consumers Union said, This will get better and the system will shake out.

You Might Also Like

  • When It Comes to Drug Development, What Do Our Dollars Buy?
  • A Look at National Health Spending
  • New Medicaid Changes in West Virginia and Kentucky May Affect Otolaryngology Practice
  • Drug Marketing: Different Impacts on Different Physicians
Explore This Issue
April 2006

Medicare Drug Plan Goes Forward

According to an article in the New England Journal of Medicine, There is already evidence that this market for prescription-drug plans is working, given the quality, cost, and range offerings.4 Authors Bach and McClellan point out that the average monthly premium, approximately $32, is lower than it was originally projected ($37); the costs to the government are approximately $15 less per month per beneficiary than was projected; and 49 states have at least one plan where the premium is $20 or less. Beneficiaries who take few prescription drugs are well served by the plans with closed formularies, where some drugs are excluded, resulting in lower premiums.

The authors also point out that competition has resulted in coverage options that are much better than those outlined in the standard benefit structure (see chart, below) in more than two-thirds of the prescription drug plans and the Medicare Advantage plans. As a result, plans are available with no deductible, with coverage for the donut hole, and with different levels of co-payments; beneficiaries can choose plans based upon their preferences and financial needs, using the government Web site www.medicare.gov or calling 1-800-Medicare.

It is likely that patients will turn to their physicians when deciding whether they should sign up for Medicare Part D. As a trusted source of information, physicians are in a position to review the patient’s medications and help to identify plans that cover these particular drugs or equivalent medications. In anticipation of this role, physicians may find the Formulary Finder at www.medicare.gov helpful in advising patients. Physicians can also stay informed by going to www.cms.hhs.gov/medicarereform/pdbma and checking the new information as it is added. There is a General Information link to the press releases, issue papers, fact sheets, and summaries of regulations. Physicians and other health care workers may participate in CMS Open Door Forums to learn more about Medicare Part D on the Web at www.cms.hhs.gov/opendoor . Fact sheets that explain Medicare’s new prescription drug coverage and help patients understand the new coverage are available there.

Pages: 1 2 3 4 | Single Page

Filed Under: Departments, Health Policy, Medical Education, Practice Management Tagged With: healthcare reform, insurance, Medicare, medication, pharmaceuticals, policy, reimbursementIssue: April 2006

You Might Also Like:

  • When It Comes to Drug Development, What Do Our Dollars Buy?
  • A Look at National Health Spending
  • New Medicaid Changes in West Virginia and Kentucky May Affect Otolaryngology Practice
  • Drug Marketing: Different Impacts on Different Physicians

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

The Triological SocietyENTtoday is a publication of The Triological Society.

Polls

Would you choose a concierge physician as your PCP?

View Results

Loading ... Loading ...
  • Polls Archive

Top Articles for Residents

  • Applications Open for Resident Members of ENTtoday Edit Board
  • How To Provide Helpful Feedback To Residents
  • Call for Resident Bowl Questions
  • New Standardized Otolaryngology Curriculum Launching July 1 Should Be Valuable Resource For Physicians Around The World
  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Popular this Week
  • Most Popular
  • Most Recent
    • A Journey Through Pay Inequity: A Physician’s Firsthand Account

    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment

    • Is Middle Ear Pressure Affected by Continuous Positive Airway Pressure Use?

    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?

    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?

    • Is Middle Ear Pressure Affected by Continuous Positive Airway Pressure Use?

    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment

    • Complications for When Physicians Change a Maiden Name

    • Excitement Around Gene Therapy for Hearing Restoration
    • “Small” Acts of Kindness
    • How To: Endoscopic Total Maxillectomy Without Facial Skin Incision
    • Science Communities Must Speak Out When Policies Threaten Health and Safety
    • Observation Most Cost-Effective in Addressing AECRS in Absence of Bacterial Infection

Follow Us

  • Contact Us
  • About Us
  • Advertise
  • The Triological Society
  • The Laryngoscope
  • Laryngoscope Investigative Otolaryngology
  • Privacy Policy
  • Terms of Use
  • Cookies

Wiley

Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1559-4939